Analysen von Emmanuel Papadakis

26.03.18 GSK overweight Barclays Capital
09.03.18 Fresenius overweight Barclays Capital
09.03.18 Fresenius Medical Care (FMC) St. Equal weight Barclays Capital
09.03.18 Bayer Underweight Barclays Capital
08.03.18 Novo Nordisk Underweight Barclays Capital
05.03.18 Bayer Underweight Barclays Capital
20.02.18 Novartis Underweight Barclays Capital
20.02.18 Sanofi Underweight Barclays Capital
05.02.18 Roche overweight Barclays Capital
25.01.18 Novartis Underweight Barclays Capital
23.01.18 Sanofi Underweight Barclays Capital
22.01.18 Bayer Underweight Barclays Capital
17.01.18 GSK overweight Barclays Capital
03.01.18 Bayer Underweight Barclays Capital
21.12.17 Roche overweight Barclays Capital
06.12.17 Bayer Underweight Barclays Capital
17.11.17 Bayer Underweight Barclays Capital
15.11.17 Sanofi Equal weight Barclays Capital
15.11.17 Novo Nordisk Underweight Barclays Capital
07.11.17 Bayer Underweight Barclays Capital
06.11.17 Bayer Underweight Barclays Capital
27.10.17 GSK Equal weight Barclays Capital
25.10.17 Novartis Underweight Barclays Capital
13.09.17 Roche overweight Barclays Capital
13.09.17 AstraZeneca overweight Barclays Capital
10.08.17 Novo Nordisk Underweight Barclays Capital
03.07.17 AstraZeneca overweight Barclays Capital
23.06.17 Novartis Equal weight Barclays Capital
13.06.17 Roche overweight Barclays Capital
02.06.17 Novartis Underweight Barclays Capital
19.05.17 Roche overweight Barclays Capital
19.05.17 Roche overweight Barclays Capital
08.05.17 Sanofi Underweight Barclays Capital
08.03.17 Novo Nordisk Underweight Barclays Capital
08.03.17 Roche overweight Barclays Capital
08.03.17 Sanofi Underweight Barclays Capital
08.03.17 GSK Equal weight Barclays Capital
08.03.17 AstraZeneca overweight Barclays Capital